FierceHealthcareFierceHealthITFierceHealthFinanceHospital Impact   FiercePharmaFierceBiotechFierceSarbox
Syndicate content

national cancer institute news from FierceHealthcare

Most Popular national cancer institute story
Related Tags Food and Drug Administration (FDA)   Democrats   Healthcare Trends   Drug Safety
Tools

News

SPOTLIGHT: Melanoma increase in young women

July 21, 2008 — 1:30am ET | By Sterling Meyers
Over the last thirty years, melanoma has increased in white women aged 15-39 at a significantly higher rate than in white men of the same age group. The report from the National Cancer Institute says... Read more...

Study: Formula underestimates blacks' breast cancer danger

November 28, 2007 — 7:59am ET
New research suggests that a formula currently used to calculate women's risk of breast cancer understates the risk for most black women, particularly those over age 50. That's a troubling failing,... Read more...

Minorities seek aggressive end-of-life care

March 12, 2007 — 8:01pm ET

Minorities continue to seek aggressive end-of-life treatment options and turn away alternatives like hospice care, research increasingly suggests. Only 7.5 percent of hospice patients are African-American, and only 4.8 percent are Hispanic--less than half of their percentage of the general population. An ongoing Harvard study funded by the National Cancer Institute involving about 800 terminally ill cancer patients is already finding that African Americans are two to three times as likely …

... Read more...

Can routine CT scans save smokers?

October 31, 2006 — 8:01pm ET

Dr. Claudia Henschke is deeply convinced that all smokers and former smokers should get routine CT scans. In a recent paper published in the New England Journal of Medicine, Dr. Henschke estimated that routine CTs could prevent as many as 80 percent of the nation's 160,000 annual deaths from lung cancer. For her study, Dr. Henschke scanned 31,567 people at more than 30 hospitals around the world. The scans found cancer in 484, with 85 percent were at Stage I. The …

... Read more...

Chemo test offers clues for patients

June 12, 2006 — 8:01pm ET

A new genetic test could help identify patients who would benefit from chemotherapy and those who would not. The National Cancer Institute is enrolling women in a major new clinical trial designed to study the effectiveness of the test for women with breast cancer. This is good news for oncologists who have argued for years that chemotherapy can be counterproductive in some cases.

The test, known as the Oncotype DX test, looks at 21 different genes that can offer a good indication …

... Read more...

NCI chief steps down

May 31, 2006 — 8:01pm ET

National Cancer Institute head Dr. Andrew von Eschenbach is leaving his job at the agency to concentrate on his role at the FDA. Critics have argued that it was inappropriate for von Eschenbach to hold the top jobs at both agencies given the potential conflicts of interest involved. Dr. John Niederhuber moves into the top spot at NCI. Washington observers doubt that von Eschenbach will be formally confirmed in his FDA role any time soon since Democrats have vowed to place a hold on his …

... Read more...

Funding inspires healthcare start-ups

April 9, 2006 — 8:01pm ET

Does government spending on healthcare R&D drive economic growth? A new study out this week argues that it does. Researchers at Indiana University and the Max Planck Institute for Economic analysis in Germany looked at the impact of grant giving by the National Cancer Institute, tracing what happened after researchers got their hands on government funding. The result, the report concludes, is far more start-up activity than had been expected. One quarter of the 1,700 researchers the …

... Read more...

Cancer funding fight shapes up on Hill

March 30, 2006 — 8:01pm ET

Cancer researchers and advocacy groups are fighting the Bush administration's plans to cut funding for the National Cancer Institute this year. Researchers have launched an Op-Ed campaign and cancer groups are planning an email and internet campaign to convince lawmakers to abandon the idea. The cuts themselves aren't particularly high--overall funding will drop from $4.75 billion to $4.5 billion, but critics say the move would be a symbolic defeat. Much of the money that could have gone …

... Read more...

Bush nominates von Eschenbach to head FDA

March 15, 2006 — 8:01pm ET

As expected, President Bush nominated Dr. Andrew von Eschenbach to head the FDA. Von Eschenbach, who is serving as the acting head of the agency, is a former head of the National Cancer Institute. Observers predict a difficult and politically-charged confirmation process. Senators Hillary Rodham Clinton (D-NY) and Patty Murray (D-WA) have vowed to block the nomination unless the agency rules on Plan B, the emergency contraceptive pill. Washington insiders say the administration is likely …

... Read more...

Von Eschenbach to get FDA nomination

March 9, 2006 — 8:01pm ET

Bush is expected to nominate acting FDA head Andrew von Eschenbach for the permanent job at the agency within the next two weeks. Dr. von Eschenbach, who moved to the FDA from the National Cancer Institute, came in as a replacement for former chairman Lester Crawford last year after his sudden exit. Von Eschenbach moved to government from the MD Anderson Cancer Center in Houston. Confirmation hearings are likely to focus on controversial issues like the debate over the agency's handling …

... Read more...
12next ›last »